Dendritic cell-based vaccines that utilize myeloid rather than plasmacytoid cells offer a superior survival advantage in malignant glioma

Mahua Dey, Alan L. Chang, Jason Miska, Derek A. Wainwright, Atique U. Ahmed, Irina V. Balyasnikova, Peter Pytel, Yu Han, Alex Tobias, Lingjiao Zhang, Jian Qiao, Maciej S. Lesniak